Synergistic cell death induction in breast cancer cell lines by combining ABT-199 and cisplatin irrespective of estrogen receptor and p53 expression.

被引：0
|
作者：
Schaefer, Benjamin [1 ,2 ]
Weller, Sandra [1 ,2 ]
Beigl, Tobias [1 ,2 ]
Boepple, Kathrin [1 ,2 ]
Hoppe, Reiner [1 ,2 ]
Schulze-Osthoff, Klaus [2 ]
Kopp, Hans-Georg [3 ,4 ]
Aulitzky, Walter E. [3 ]
Essmann, Frank [1 ,2 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[2] Univ Tubingen, Stuttgart, Germany
[3] Robert Bosch Krankenhaus, Stuttgart, Germany
[4] Robert Bosch Ctr Tumor Dis, Stuttgart, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1946
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression pattern of the apoptosis-stimulating protein of p53 family in p53+ human breast cancer cell lines
    Changsong Wang
    Chunfang Gao
    Yanping Chen
    Jian Yin
    Ping Wang
    Xuexia Lv
    Cancer Cell International, 13
  • [22] Vinorelbine induces p38 but not mapk activation nor p53 expression in breast cancer cell lines
    Liem, AA
    Appleyard, MVCL
    O'Neill, MA
    Hupp, TR
    Chamberlain, MP
    Wolf, CR
    Thompson, AM
    BRITISH JOURNAL OF CANCER, 2002, 86 : S89 - S90
  • [23] KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer
    Rokhlin, Oskar W.
    Guseva, Natalya V.
    Taghiyev, Agshin F.
    Glover, Rebecca A.
    Cohen, Michael B.
    CANCER BIOLOGY & THERAPY, 2010, 9 (03) : 223 - 234
  • [24] Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines
    Woessmann, W
    Chen, XB
    Borkhardt, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (05) : 397 - 404
  • [25] Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines
    Willi Woessmann
    Xinbin Chen
    Arndt Borkhardt
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 397 - 404
  • [26] Differences in the levels, localization and DNA binding of p53 in breast cancer cell lines
    Ray, Debolina
    Murphy, Keith R.
    Gal, Susannah
    CANCER RESEARCH, 2012, 72
  • [27] Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis
    Huovinen, Marjo
    Loikkanen, Jarkko
    Myllynen, Paivi
    Vahakangas, Kirsi H.
    TOXICOLOGY IN VITRO, 2011, 25 (05) : 1007 - 1017
  • [28] p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
    Fernandez-Cuesta, Lynnette
    Anaganti, Suresh
    Hainaut, Pierre
    Olivier, Magali
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (08) : 1813 - 1821
  • [29] Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines
    Salem, Sameer D.
    Abou-Tarboush, Faisal M.
    Saeed, Nadeem M.
    Al-Qadasi, Waheeb D.
    Farah, M. Abul
    Al-Buhairi, Muneera
    Al-Harbi, Najla
    Alhazza, Ibrahim
    Alsbeih, Ghazi
    GENE, 2012, 498 (02) : 300 - 307
  • [30] Correction to: The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines
    Hyeong Sim Choi
    Young-Kyun Kim
    Pil-Young Yun
    Molecular Biology Reports, 2021, 48 : 7057 - 7057
12345